CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-07 | MacKenzie Lloyd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2018-03-15 | MacKenzie Lloyd Chief Operating Officer | Exercise or conversion | +1,302 | $10.56 | $14K | 1,302 |
| 2018-03-15 | MacKenzie Lloyd Chief Operating Officer | Sale | −1,302 | $14.63 | $19K | 0 |
| 2018-03-15 | MacKenzie Lloyd Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,302 | 0 | ||
| 2018-03-09 | MacKenzie Lloyd Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2017-03-08 | MacKenzie Lloyd VP Technical Operations | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2016-03-10 | MacKenzie Lloyd VP Technical Operations | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion | +7,812 | $5.76 | $45K | 7,812 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion | +28,075 | $5.76 | $162K | 35,887 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Sale | −35,887 | $18.67 | $670K | 0 |
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | +7,812 | 0 | ||
| 2015-08-12 | MacKenzie Lloyd VP Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | +28,075 | 1,872 | ||
| 2015-03-12 | MacKenzie Lloyd VP Technical Operations | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2014-05-08 | MacKenzie Lloyd VP Technical Operations | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 14 trades